Avery Dennison appoints Dean Scarborough as chairman

Avery Dennison’s board of directors has elected president and CEO Dean A. Scarborough to succeed Kent Kresa as chairman of the board and selected director David E. I. Pyott as lead independent director. Pyott, chairman and chief executive officer of Allergan, is one of 10 independent directors on Avery Dennison's 12-person board.

The changes will take effect upon Kresa's retirement on April 22, 2010 at the annual shareholders meeting, in accordance with the company’s policy that directors retire at the age of 72. As chairman, Scarborough will continue in his roles as president and chief executive officer.

Avery Dennison chairman Kent Kresa said: ‘In the five years that Dean Scarborough has been CEO, he has led Avery Dennison’s global expansion and guided the company during an exceptionally challenging recession. He has built a strong management team and led the development and implementation of a sound strategy for future growth. I have enjoyed working with Dean and my other fellow directors, and I am confident in the new leadership structure of the board.’ 

Click here for more stories about Avery Dennison on L&L.com.